AAPL338.98+2.31 (+0.69%) ▲|ABBV270.05-1.32 (-0.48%) ▼|ABT98.51-0.22 (-0.22%) ▼|ACN203.30+6.66 (+3.38%) ▲|ADBE234.94+2.17 (+0.93%) ▲|AMAT508.06-12.59 (-2.42%) ▼|AMD619.14-26.73 (-4.14%) ▼|AMGN406.38-6.71 (-1.62%) ▼|AMT166.30+0.12 (+0.07%) ▲|AMZN254.39-5.53 (-2.13%) ▼|AVGO361.02-15.49 (-4.11%) ▼|AXP304.43+0.18 (+0.06%) ▲|BA186.94-1.39 (-0.74%) ▼|BAC53.11-0.41 (-0.77%) ▼|BKNG158.85+2.98 (+1.91%) ▲|BLK1,065.90-3.73 (-0.35%) ▼|BMY59.47-0.23 (-0.39%) ▼|BNY143.13+0.41 (+0.28%) ▲|BRK-B512.47+6.22 (+1.23%) ▲|C127.81+0.49 (+0.38%) ▲|CAT799.79-14.05 (-1.73%) ▼|CL88.24+1.03 (+1.18%) ▲|CMCSA21.14+0.20 (+0.96%) ▲|COF196.56+0.65 (+0.33%) ▲|COP134.35+4.51 (+3.47%) ▲|COST948.56+6.31 (+0.67%) ▲|CRM224.11-0.45 (-0.20%) ▼|CSCO116.26-1.13 (-0.96%) ▼|CVS88.24+0.29 (+0.33%) ▲|CVX211.58+6.43 (+3.13%) ▲|DE651.71-5.16 (-0.79%) ▼|DHR215.99-2.50 (-1.14%) ▼|DIS106.72+1.97 (+1.88%) ▲|DUK116.30+0.80 (+0.69%) ▲|EMR157.86-1.37 (-0.86%) ▼|FDX290.46+1.42 (+0.49%) ▲|GD329.14+2.51 (+0.77%) ▲|GE305.56+1.94 (+0.64%) ▲|GEV992.09-5.00 (-0.50%) ▼|GILD146.46-0.40 (-0.27%) ▼|GM81.88+0.89 (+1.10%) ▲|GOOG343.75-3.63 (-1.04%) ▼|GOOGL346.72-3.78 (-1.08%) ▼|GS880.51-6.71 (-0.76%) ▼|HD294.75+8.98 (+3.14%) ▲|HON206.34-1.77 (-0.85%) ▼|IBM223.77+3.26 (+1.48%) ▲|INTC106.03-7.09 (-6.27%) ▼|INTU297.74+1.88 (+0.64%) ▲|ISRG415.60+1.08 (+0.26%) ▲|JNJ255.51-2.95 (-1.14%) ▼|JPM330.46+0.88 (+0.27%) ▲|KO87.97+2.15 (+2.50%) ▲|LIN483.28-0.70 (-0.14%) ▼|LLY1,153.91-34.81 (-2.93%) ▼|LMT506.51+7.29 (+1.46%) ▲|LOW188.49+6.95 (+3.83%) ▲|LRCX320.42-9.09 (-2.76%) ▼|MA580.21+10.15 (+1.78%) ▲|MCD236.91+6.03 (+2.61%) ▲|MDLZ60.59+1.21 (+2.04%) ▲|MDT87.97+2.46 (+2.88%) ▲|META716.92-4.39 (-0.61%) ▼|MMM163.60+1.48 (+0.91%) ▲|MO71.54+2.16 (+3.11%) ▲|MRK141.14-1.65 (-1.16%) ▼|MS186.71-3.00 (-1.58%) ▼|MSFT519.58-10.18 (-1.92%) ▼|MU1,038.36-49.64 (-4.56%) ▼|NEE77.14+0.08 (+0.10%) ▲|NFLX70.90+1.20 (+1.72%) ▲|NKE34.60+0.24 (+0.68%) ▲|NOW137.19-0.68 (-0.49%) ▼|NVDA230.47-7.00 (-2.95%) ▼|ORCL137.13-6.43 (-4.48%) ▼|PEP126.84+3.11 (+2.51%) ▲|PFE27.80-0.21 (-0.73%) ▼|PG150.48+2.66 (+1.80%) ▲|PLTR196.45+2.33 (+1.20%) ▲|PM201.76+9.07 (+4.71%) ▲|QCOM173.14-3.99 (-2.25%) ▼|RTX183.85+3.59 (+1.99%) ▲|SBUX89.86-3.73 (-3.98%) ▼|SCHW96.58+1.00 (+1.05%) ▲|SO85.81+0.37 (+0.43%) ▲|SPG199.50+1.91 (+0.97%) ▲|T24.95+0.48 (+1.94%) ▲|TMO649.30-12.76 (-1.93%) ▼|TMUS171.20+3.55 (+2.11%) ▲|TSLA370.91-6.90 (-1.83%) ▼|TXN286.77-2.21 (-0.76%) ▼|UBER69.36+0.91 (+1.32%) ▲|UNH372.04-3.94 (-1.05%) ▼|UNP277.25+2.57 (+0.93%) ▲|UPS93.78+1.49 (+1.61%) ▲|USB56.77+0.60 (+1.06%) ▲|V379.48+7.38 (+1.98%) ▲|VZ46.50+0.73 (+1.58%) ▲|WFC81.58+1.32 (+1.64%) ▲|WMT110.81+2.65 (+2.45%) ▲|XOM168.69+4.64 (+2.83%) ▲|AAPL338.98+2.31 (+0.69%) ▲|ABBV270.05-1.32 (-0.48%) ▼|ABT98.51-0.22 (-0.22%) ▼|ACN203.30+6.66 (+3.38%) ▲|ADBE234.94+2.17 (+0.93%) ▲|AMAT508.06-12.59 (-2.42%) ▼|AMD619.14-26.73 (-4.14%) ▼|AMGN406.38-6.71 (-1.62%) ▼|AMT166.30+0.12 (+0.07%) ▲|AMZN254.39-5.53 (-2.13%) ▼|AVGO361.02-15.49 (-4.11%) ▼|AXP304.43+0.18 (+0.06%) ▲|BA186.94-1.39 (-0.74%) ▼|BAC53.11-0.41 (-0.77%) ▼|BKNG158.85+2.98 (+1.91%) ▲|BLK1,065.90-3.73 (-0.35%) ▼|BMY59.47-0.23 (-0.39%) ▼|BNY143.13+0.41 (+0.28%) ▲|BRK-B512.47+6.22 (+1.23%) ▲|C127.81+0.49 (+0.38%) ▲|CAT799.79-14.05 (-1.73%) ▼|CL88.24+1.03 (+1.18%) ▲|CMCSA21.14+0.20 (+0.96%) ▲|COF196.56+0.65 (+0.33%) ▲|COP134.35+4.51 (+3.47%) ▲|COST948.56+6.31 (+0.67%) ▲|CRM224.11-0.45 (-0.20%) ▼|CSCO116.26-1.13 (-0.96%) ▼|CVS88.24+0.29 (+0.33%) ▲|CVX211.58+6.43 (+3.13%) ▲|DE651.71-5.16 (-0.79%) ▼|DHR215.99-2.50 (-1.14%) ▼|DIS106.72+1.97 (+1.88%) ▲|DUK116.30+0.80 (+0.69%) ▲|EMR157.86-1.37 (-0.86%) ▼|FDX290.46+1.42 (+0.49%) ▲|GD329.14+2.51 (+0.77%) ▲|GE305.56+1.94 (+0.64%) ▲|GEV992.09-5.00 (-0.50%) ▼|GILD146.46-0.40 (-0.27%) ▼|GM81.88+0.89 (+1.10%) ▲|GOOG343.75-3.63 (-1.04%) ▼|GOOGL346.72-3.78 (-1.08%) ▼|GS880.51-6.71 (-0.76%) ▼|HD294.75+8.98 (+3.14%) ▲|HON206.34-1.77 (-0.85%) ▼|IBM223.77+3.26 (+1.48%) ▲|INTC106.03-7.09 (-6.27%) ▼|INTU297.74+1.88 (+0.64%) ▲|ISRG415.60+1.08 (+0.26%) ▲|JNJ255.51-2.95 (-1.14%) ▼|JPM330.46+0.88 (+0.27%) ▲|KO87.97+2.15 (+2.50%) ▲|LIN483.28-0.70 (-0.14%) ▼|LLY1,153.91-34.81 (-2.93%) ▼|LMT506.51+7.29 (+1.46%) ▲|LOW188.49+6.95 (+3.83%) ▲|LRCX320.42-9.09 (-2.76%) ▼|MA580.21+10.15 (+1.78%) ▲|MCD236.91+6.03 (+2.61%) ▲|MDLZ60.59+1.21 (+2.04%) ▲|MDT87.97+2.46 (+2.88%) ▲|META716.92-4.39 (-0.61%) ▼|MMM163.60+1.48 (+0.91%) ▲|MO71.54+2.16 (+3.11%) ▲|MRK141.14-1.65 (-1.16%) ▼|MS186.71-3.00 (-1.58%) ▼|MSFT519.58-10.18 (-1.92%) ▼|MU1,038.36-49.64 (-4.56%) ▼|NEE77.14+0.08 (+0.10%) ▲|NFLX70.90+1.20 (+1.72%) ▲|NKE34.60+0.24 (+0.68%) ▲|NOW137.19-0.68 (-0.49%) ▼|NVDA230.47-7.00 (-2.95%) ▼|ORCL137.13-6.43 (-4.48%) ▼|PEP126.84+3.11 (+2.51%) ▲|PFE27.80-0.21 (-0.73%) ▼|PG150.48+2.66 (+1.80%) ▲|PLTR196.45+2.33 (+1.20%) ▲|PM201.76+9.07 (+4.71%) ▲|QCOM173.14-3.99 (-2.25%) ▼|RTX183.85+3.59 (+1.99%) ▲|SBUX89.86-3.73 (-3.98%) ▼|SCHW96.58+1.00 (+1.05%) ▲|SO85.81+0.37 (+0.43%) ▲|SPG199.50+1.91 (+0.97%) ▲|T24.95+0.48 (+1.94%) ▲|TMO649.30-12.76 (-1.93%) ▼|TMUS171.20+3.55 (+2.11%) ▲|TSLA370.91-6.90 (-1.83%) ▼|TXN286.77-2.21 (-0.76%) ▼|UBER69.36+0.91 (+1.32%) ▲|UNH372.04-3.94 (-1.05%) ▼|UNP277.25+2.57 (+0.93%) ▲|UPS93.78+1.49 (+1.61%) ▲|USB56.77+0.60 (+1.06%) ▲|V379.48+7.38 (+1.98%) ▲|VZ46.50+0.73 (+1.58%) ▲|WFC81.58+1.32 (+1.64%) ▲|WMT110.81+2.65 (+2.45%) ▲|XOM168.69+4.64 (+2.83%) ▲|
23.7 C
New York
Thursday, October 8, 2026

Tag: company

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)

Indivior Announces Completion of Cancellation of Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained

SLOUGH, United Kingdom and RICHMOND, Va., July 25, 2025 /PRNewswire/ -- Further to the announcement made on June 2, 2025, Indivior PLC (Nasdaq: INDV)...

MORITO CO., LTD. Commemorates 30th Anniversary of Airing of Neon Genesis Evangelion with First Collaborative Bags by 52 BY HIKARUMATSUMURA

- Special Models Inspired by Unit-01 and Unit-02, Products Available in Limited Quantities for Limited Time from July 15, 2025 - OSAKA, Japan, July 25,...

Loomis Interim Report January – June 2025

STOCKHOLM, July 25, 2025 /PRNewswire/ -- A solid organic growth and strong operating margin We had a solid performance in the second quarter. Revenues reached SEK...

BW Energy: Invitation to Q2 2025 and half-year results presentation 01 August 

Invitation to Q2 2025 and half-year results presentation 01 August  

Memo Therapeutics AG Announces Phase II Trial Results for Potravitug in Kidney Transplant Recipients with BKPyV Infection

Schlieren / Zurich, Switzerland, 25 July, 2025 – Memo Therapeutics AG ("MTx”), a late-stage biotech company translating unique immune responses into superior medicines to treat viral infections and cancer, today announced results from its Phase II clinical trial evaluating potravitug, a highly potent human BK polyomavirus (“BKPyV”)-neutralizing monoclonal antibody, for the treatment of BKPyV infection in kidney transplant recipients (“KTR”).

Hexaware Delivers Solid Q2CY25 Revenue of USD 382.1 Mn, Up 8.6% YoY

Q2CY25 EBITDA Expansion of 156 bps YoY Q2CY25 EPS at INR 6.25 Increase of 37.7% YoY ISELIN, N.J., July 25, 2025 /PRNewswire/ -- Hexaware Technologies (NSE:...

Bitget KCGI 2025 Heats Up as Team Battle Kicks Off: Communities Unite, Rivalries Ignite

Bitget launches KCGI 2025 Team Battle with 6M USDT prize pool, global captains, and over 1,300 teams in fierce competition.

CWE held “Lancang Mekong Green Course” Open Day to celebrate the 10th anniversary of the Nam Ngiep 2 Hydropower Station

VIENTIANE, Laos, July 24, 2025 (GLOBE NEWSWIRE) -- To celebrate the 10th anniversary of the commissioning and operation of the Nam Ngiep 2 Hydropower Station in Laos, China International Water & Electric Corp. (CWE), a subsidiary of China Communications Construction Company (CCCG), held “Lancang Mekong Green Course” Open Day event from July 4 to 5, 2025. The event drew wide participation from students and faculty of the National University of Laos, government representatives at various levels, and residents from surrounding communities, who came together to witness the station’s achievements over the past decade.

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public.

RDDT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Reddit, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in...

New York, July 24, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Reddit, Inc. (NYSE: RDDT) between October 29, 2024 and May 20, 2025, both dates inclusive (the “Class Period”), of the important August 18, 2025 lead plaintiff deadline.

ROSEN, A LEADING LAW FIRM, Encourages Petco Health and Wellness Company, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action –...

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) between January 14, 2021 and June 5, 2025, both dates inclusive (the “Class Period”), of the important August 29, 2025 lead plaintiff deadline.

GeeTest Releases 2025 E-commerce Industry Security White Paper to Strengthen Online Retail Protection

WUHAN, China, July 25, 2025 /PRNewswire/ -- GeeTest, a global leader in bot mitigation and business security, has released its 2025 E-commerce Industry Security...

Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million

SHANGHAI, July 25, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompany